Independent Financial Group LLC Makes New $602,000 Investment in National Health Investors, Inc. $NHI

Independent Financial Group LLC bought a new position in National Health Investors, Inc. (NYSE:NHI) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 7,443 shares of the real estate investment trust’s stock, valued at approximately $602,000.

Several other hedge funds have also recently modified their holdings of the business. Principal Financial Group Inc. raised its position in National Health Investors by 2.0% in the 1st quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock worth $137,537,000 after buying an additional 32,902 shares during the last quarter. Chicago Partners Investment Group LLC purchased a new stake in shares of National Health Investors during the 1st quarter valued at about $218,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in shares of National Health Investors by 39.0% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 21,152 shares of the real estate investment trust’s stock worth $1,710,000 after acquiring an additional 5,938 shares during the period. Hsbc Holdings PLC raised its holdings in shares of National Health Investors by 12.1% during the first quarter. Hsbc Holdings PLC now owns 84,520 shares of the real estate investment trust’s stock valued at $6,834,000 after purchasing an additional 9,094 shares during the last quarter. Finally, Resona Asset Management Co. Ltd. raised its holdings in shares of National Health Investors by 4.7% during the first quarter. Resona Asset Management Co. Ltd. now owns 21,067 shares of the real estate investment trust’s stock valued at $1,734,000 after purchasing an additional 940 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Analyst Ratings Changes

NHI has been the topic of several research reports. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. BMO Capital Markets decreased their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Deutsche Bank Aktiengesellschaft dropped their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Truist Financial cut their price objective on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a report on Friday, June 12th. Finally, Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Five research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, National Health Investors presently has an average rating of “Moderate Buy” and an average price target of $83.86.

Insider Buying and Selling at National Health Investors

In related news, CEO D. Eric Mendelsohn bought 1,500 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This represents a 2.06% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 2.70% of the company’s stock.

National Health Investors Stock Performance

Shares of NYSE NHI opened at $80.04 on Thursday. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The firm has a market capitalization of $3.88 billion, a price-to-earnings ratio of 25.82, a price-to-earnings-growth ratio of 3.64 and a beta of 0.51. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The firm has a 50 day moving average of $74.80 and a 200 day moving average of $79.69.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s dividend payout ratio is 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.